The County Health Officer and Co-chair on the Bomi County Taskforce, Dr. G. Gorbee Logan, has told the Daily Observer that he needs more support for his experiment, which he has used to “cure” at least 10 persons who once tested positive with Ebola.
He, however, stressed to the Observer that it was yet too early to say that his experiment was working or works effectively against the deadly disease, which has so far killed over 2000 persons in Liberia alone. He said he determined to carry out the test on as many as 500 patients so as to validate his claim that his self-invented protocol works well against the virus.
Dr. Logan administered Lamivudine drug through his protocol to cure the 10 Ebola patients in Bomi County, with several others on medication in the Ebola Treatment Unit.
Speaking on Friday at the reunification and certification program of the Ebola disease survivors in Tubmanburg, Bomi County, Dr. Logan said, the using of Lamivudine drug on affected Ebola patients was due to some similarity between the Human Immuno Virus (HIV) and the Ebola virus.
He explained that HIV is a single stranded ribonucleic acid virus (SS-RNA) while the Ebola virus is the same.
According to Dr. Logan, “If this Lamivudine drug can be used to cure hepatitis and also in combination with Zidovudine to treat HIV, and the question then asked was, would this help to cure Ebola virus? when would this research and study be conducted when our people are dying? I decided to try this medication on 15 persons.”
According to the U.S. Nation Institutes of Health, Lamivudine is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). It works by decreasing the amount of HIV and hepatitis B in the blood. Although lamivudine does not cure HIV, it may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. The drug, when used alone or in combination with other antiviral medications, can cause serious damage to the liver and a condition called lactic acidosis. Therefore it must be prescribed following tests administered by a medical doctor and monitored for side effects on a patient by patient basis.
Dr. Logan continued that along the way of trying the medication on 15 patients who blood samples were tested positive at the Liberia Institute of Biomedical Research (LIBR) earlier, 10 survived and the treatment continued up to date for other patients, who still in the ETU.
According to Dr. Logan, the Lamivudine drug is in the list of World Health Organization (WHO) essential drugs that is approved for used and he did not manufactured the drug.
He explained that only people who come for early treatment can be provided the Lamivudine drug especially from the first day of the symptoms of Ebola to the fifth day, adding that, “Not only Lamivudine drug that is needed to cure Ebola patients and anyone who comes late cannot be given the drug.”
According to him, blood samples of the 10 were taken and tested by all professional doctors and nurses including people from the Centers for Disease Control (CDC) as well as other international partners working in collaboration with the County Task Force in Bomi.
The 10 persons who survived of the deadly Ebola virus disease include: Promise Galakemene, Kula Coleman, Patience Kamara, Susan K. Kamara, Bendu Kamara, Fatee Sheriff, Elizabeth Kundo, Jowel Khovoy, Tenenie Golafaley and Charles Roberts.